Presented by Parent-Volunteers from the WV Branch of
JDRF
(Juvenile Diabetes Research Foundation)

My #1

Interview with an adult type 1

Her #1?

Her #1?
Right after diagnosis,
Alyssa’s #1s were:
 Her parents
 Her teachers
 Her school nurse

Her #1?
Right after diagnosis,
Alyssa’s #1s were:
 Her parents
 Her teachers
 Her school nurse
In Junior High:
“I loved my school nurse in junior high. If the teachers sucked, it was nice to have someone at school to give you support.
“ The school nurse is a big part of a diabetic child’s life, because they understand the disease better than the teachers. They are your medical parent away from home, quietly making sure that you check your
BG’s and take your insulin, but at the same time making you more accountable than your overprotective parents do.
I didn’t need someone telling me everything little thing, but I did need to know that if I forgot, my school nurse was there to remind me.”

YOU ARE!

YOU ARE!

You are our hero!

 You help us get through each day, when you get the resources for our child’s care.
You are our hero!

 You allow us some freedom because we know we can depend on you during the school day.
You are our hero!

help

JDRF Brand
The word "juvenile" is no longer descriptive of the disease or those burdened with it. JDRF market research tells us that, today, 85 percent of those in the U.S with type 1 diabetes are adults. We want to communicate that
JDRF is an organization for ALL ages, and ALL stages of this disease.

P
R
O
G
R
A
M
N
T
M
E
O
R

WALK
CURE
DIABETES
TO

Second Annual West Virginia Branch of JDRF Diabetes Symposium
October 12-13, 2013
Days Inn Hotel and Conference Center,
Flatwoods, WV
$89 room rates available for attendees!
Sessions for all ages!
-Kids!
-Teens!
-Adults!
Tom Brobson, with JDRF’s Artificial
Pancreas Project to be our keynote speaker

It's fun , it's easy , and it's educational !
And... it's all about
Kids Helping Kids!
JDRF staff tailored the program and worked with us in a very professional, uplifting, and empowering way.
Steven Bollar, Principal
Hartford School, Mount Laurel, NJ

TypeOneNation.org is a vibrant social network created especially for and by people with type 1 diabetes and their loved ones.
It was launched by JDRF on
World Diabetes Day, November
14, 2008.
Stay connected.
Be social.
Like/Follow us on
Facebook and Twitter.

JDRF is the
ONLY global organization with a strategic plan to progressively remove the impact of T1D from people's lives until it is no longer a threat to anyone .
JDRF
Research

 C URE R ESEARCH P ROGRAM
 T REAT R ESEARCH P ROGRAM
 P REVENT R ESEARCH P ROGRAM
JDRF
Research

TOP RESEARCH HIGHLIGHTS
Discovery of New Hormone
May Impact T1D
The previously unknown hormone, called betatrophin, has been found to promote the natural replication of beta cells.
JDRF’s vice president, cure therapies, Julia Greenstein, Ph.D., states: “It’s still too early to tell if there would even be any implications for people with type 1 diabetes…[It] is certainly interesting.”

TOP RESEARCH HIGHLIGHTS
New Insights into Factors Affecting
T1D Development
JDRF-funded researchers have determined that early-life exposure to normal gut bacteria protects against autoimmune disease.
“Our findings suggest potential strategies for using normal gut bacteria to block progression of insulin-dependent diabetes in kids who have high genetic risk,” says
Jayne Danska, Ph.D., senior scientist in genetics at The Hospital for Sick Children in
Toronto.

TOP RESEARCH HIGHLIGHTS
Pancreas Size Linked to
Type 1 Diabetes Development
Researchers at the University of Florida weighed pancreases donated to the Network for Pancreatic Organ Donors with
Diabetes (nPOD) and found that donors at risk of developing T1D have smaller pancreases and fewer insulin-producing beta cells than people who are not at risk for disease.
The data obtained suggests that lower pancreas weight may be attributable to a lower number of insulin-producing beta cells.

TOP RESEARCH HIGHLIGHTS
Using Tiny Particles Helps Reset the Immune System
A recent JDRF-funded study has confirmed that incorporating nanoparticles into the antigen-specific immune therapy that targets only a misguided part of the immune system could help stop the process that triggers various autoimmune diseases, including T1D.
The researcher at Northwestern University specifically used this therapy for the treatment for the autoimmune disease multiple sclerosis (MS).

TOP RESEARCH HIGHLIGHTS
JDRF Forms New Partnership to Develop
Dual-Hormone Infusion Pump
The recent partnership with Tandem Diabetes Care is focused on developing the world’s first dual-chamber hormone pump that can deliver 2 injectable hormones simultaneously to help regulated BG levels. It is hoped that this could be used with glucagon and Symlin (an analog of the hormone amylin used to control the rate at which glucose enters the bloodstream after meals).

TOP RESEARCH HIGHLIGHTS
Tom Brobson,
JDRF’s national director of research investment opportunities, who has doubled as a test subject for
JDRF’s Artificial Pancreas Project for the past six years.